Navigation Links
MUHC scientists describe genetic resistance to rampant virus

MUHC researchers have defined genetic resistance to the widespread virus, cytomegalovirus (CMV)--a member of the viral group that causes some of the world's most prevalent diseases, such as herpes, chicken pox and mononucleosis. The groundbreaking research published in Nature Genetics last week, provides a roadmap for the development of human therapies for CMV, which could prolong the life of HIV patients and improve the success of transplant surgery by reducing the risk of rejection. There is currently no treatment or cure for CMV.

Resistance to diseases like CMV depends, at least partially, on the ability of our body's defense mechanism to recognize and destroy them. "Detecting these pathogens is not always easy," says Dr. Silvia Vidal, a Canada Research Chair in Host Response to Virus Infection based at the MUHC and lead author of the new research. "CMV has developed cunning disguises to avoid detection by our Natural Killer cells--one of several cell types that hunt-down and terminate unwelcome invaders within our body." Our Natural Killer cells and the pathogens they fight have been locked in an evolutionary arms race for millions of years in an attempt to overwhelm each other.

Dr. Vidal and her team have spent the past 10 years studying CMV-resistant mouse strains in an attempt to describe the nature of their genetic resistance. "This research marks our second discovery of genetic resistance to CMV," she says. Most significantly, this new research documents an entirely new mechanism of resistance to CMV, involving the interaction between two genes. One gene flags virus-infected cells for destruction, the other gene allows our Natural Killers cells to recognize and terminate them. "This is a new concept in natural disease resistance," notes Dr. Vidal. "Our research suggests there are many different mechanisms for fighting viruses; in the future we expect to discover additional resistant genotypes."

CMV infects most of the world's organism s, including upwards of 80% of the human population. Although healthy people suffer only mild symptoms, infection can trigger fatal reactions in those with a compromised immune system, such as organ transplant recipients, newborns and persons infected with human immunodeficiency virus (HIV). Dr. Vidal believes her groundbreaking discovery increases the likelihood that therapies will be developed to fight CMV.


'"/>

Source:McGill University


Related biology news :

1. Wisconsin scientists grow critical nerve cells
2. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
3. UAB scientists discover the origin of a mysterious physical force
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
6. U-M scientists find genes that control growth of common skin cancer
7. UCLA scientists transform HIV into cancer-seeking missile
8. RNA project to create language for scientists worldwide
9. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
10. To control germs, scientists deploy tiny agents provocateurs
11. Leprosy microbes lead scientists to immune discovery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... 23, 2017  The general public,s help is being enlisted in what,s ... live in and on the human body –and are believed to affect ... The Microbiome Immunity Project is ... starting with the gut. The project's goal is to help advance scientific ... ...
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017 /PRNewswire/ ... leader in dairy research, today announced a new collaboration ... reduce the chances that the global milk supply is ... dairy project, Cornell University has become the newest academic ... Supply Chain, a food safety initiative that includes IBM ...
(Date:5/16/2017)... 16, 2017   Bridge Patient Portal , ... MD EMR Systems , an electronic medical ... GE, have established a partnership to build an ... the GE Centricity™ products, including Centricity Practice Solution ... These new integrations will allow healthcare delivery ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/11/2017)... Austin, TX (PRWEB) , ... October 11, 2017 ... ... in August compared the implantation and pregnancy rates in frozen and fresh ... the contribution of progesterone and maternal age to IVF success. , After comparing ...
(Date:10/10/2017)... ... ... San Diego-based team building and cooking events company, Lajollacooks4u, has unveiled a ... new look is part of a transformation to increase awareness, appeal to new markets ... It will also expand its service offering from its signature gourmet cooking classes and ...
(Date:10/10/2017)... Philadelphia, PA (PRWEB) , ... October 10, 2017 ... ... University City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. ... accept the award for Excellence in Volunteer Experience from US2020. , US2020’s mission ...
Breaking Biology Technology: